CMS now covers a take-home supply of nasal Naloxone

Effective January 1, 2022, Medicare covers HCPCS Code G1028 (take-home supply of nasal Naloxone; 2-pack of 8mg per 0.1 mL nasal spray) per the Medicare opioid treatment program.

You need to be logged in to view the rest of the content. Please . Not a Member? Join Us

Discover more from Doctor Trusted

Subscribe to get the latest posts sent to your email.